<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00848952</url>
  </required_header>
  <id_info>
    <org_study_id>PHRC 2008-01</org_study_id>
    <nct_id>NCT00848952</nct_id>
  </id_info>
  <brief_title>Performance of Imaging for the Diagnosis of Small Hepatocellular Carcinoma (&lt; 3 cm)on Cirrhosis</brief_title>
  <acronym>CHIC</acronym>
  <official_title>Performance of Imaging for the Diagnosis of Small Hepatocellular Carcinoma (&lt; 3 cm)on Cirrhosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Angers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Angers</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate 3 imaging techniques and their associations : MRI,
      CTscanner and enhanced contrast ultrasound for the diagnosis of small (&lt; 3 cm) hepatocellular
      carcinoma for patients with cirrhosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      With the improvement of cirrhosis complications coverage, hepatocellular carcinoma (HCC) tend
      to become the main cause of mortality for cirrhotic patients. Currently, the incidence of the
      HCC increase in occidental country and hid global prognostic remain very bad. The main
      indication factor for a curative treatment is the size lesion.

      Cirrhosis is the main risk factor for HCC occurence. In France, HCC screening has been
      establish for cirrhotic patients with hepatic ultrasound and alfa-fetoprotein measurement
      with the aim of detected HCC when the size allows a curative treatment.

      When a nodule is discovered during the follow-up, HCC diagnosis is done following the
      recommendations of European Association for the Study of the Liver (AESL) in 2000, updated by
      the American Association for the Study of Liver Diseases (AASLD)in 2005. Diagnostic is
      function of nodule feature on one or two enhanced imaging techniques among CTscanner, MRI and
      enhanced contrast ultrasound.

      This diagnostic strategy raises several questions. First, neither the most efficient dynamic
      imaging association for nodules from 1 to 2 cm, nor the most efficient imaging examination
      for nodules from 2 to 3 cm are known. Second, only few studies have been carried out about
      imaging semiology of the small hepatocellular carcinoma. Thus, the imprecisions of the
      present recommendations regarding the choice of the best examination technique and the
      difficulties in the diagnosis of benign or malignant nature for small nodule can lead to a
      bad management of these patients.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2009</start_date>
  <primary_completion_date type="Anticipated">March 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Report of proportion of the positives truths and the positive wrong for an examination</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Hepatocellular Carcinoma</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>3 imaging techniques are done</intervention_name>
    <description>all patients have : MRI, CTscanner, enhanced contrast ultrasound</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 18 hears

          -  presence of one or several nodules &lt; 3 cm

          -  known or suspected cirrhosis

        Exclusion Criteria:

          -  psychiatric disease

          -  contraindication to one of the 3 imaging examinations (CTscanner, MRI, enhanced
             contrast ultrasound

          -  patient already treated by chemoembolization

          -  recurrence on the coagulation zone of a nodule already treated by per-cutaneous tumour
             destruction

          -  presence of a tumour (&gt; 3 cm) associated to the nodule

          -  pregnant woman or breast-feeding woman
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christophe Aube, professor</last_name>
    <phone>33-(0)2-41-35-42-81</phone>
    <email>chaube@chu-angers.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Angers</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aubé Christophe</last_name>
      <email>chaube@chu-angers.fr</email>
    </contact>
    <investigator>
      <last_name>Aubé Christophe</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint-André</name>
      <address>
        <city>Bordeaux</city>
        <zip>33300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Trillaud</last_name>
      <email>herve.trillaud@chu-bordeaux.fr</email>
    </contact>
    <investigator>
      <last_name>Trillaud</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu</name>
      <address>
        <city>Caen</city>
        <zip>14033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Le Pennec</last_name>
      <email>lepennec-v@chu-caen.fr</email>
    </contact>
    <investigator>
      <last_name>Le Pennec</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>hôpital Beaujon</name>
      <address>
        <city>Clichy</city>
        <zip>92110</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vilgrain</last_name>
      <email>valerie.vilgrain@bjn.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Valérie Vilgrain</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>hôpital Henri Mondor</name>
      <address>
        <city>Créteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Luciani</last_name>
      <email>alain.luciani@hmn.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Luciani</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Du Bocage</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Krause</last_name>
      <email>denis.krause@chu-dijon.fr</email>
    </contact>
    <investigator>
      <last_name>Krause</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bricault</last_name>
      <email>IBricault@chu-grenoble.fr</email>
    </contact>
    <investigator>
      <last_name>Bricault</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital de la croix rousse</name>
      <address>
        <city>Lyon</city>
        <zip>69317</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rode</last_name>
      <email>agnes.rode@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Rode</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital E. Herriot</name>
      <address>
        <city>Lyon</city>
        <zip>69437</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pilleul</last_name>
      <email>frank.pilleul@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Pilleul</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint Éloi</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gallix</last_name>
      <email>b-gallix@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Gallix</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Brabois</name>
      <address>
        <city>Nancy</city>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laurent</last_name>
      <email>v.laurent@chu-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>Laurent</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Hôtel Dieu</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dupas</last_name>
      <email>benoit.dupas@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Dupas</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>hôpital archet II</name>
      <address>
        <city>Nice</city>
        <zip>06003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chevallier</last_name>
      <email>chevallier.p@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>Chevallier</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint Antoine</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lewin</last_name>
      <email>maite.lewin@sat.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Lewin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Haut-Lévèque</name>
      <address>
        <city>Pessac</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Drouillard</last_name>
      <email>jacques.drouillard@chu-bordeaux.fr</email>
    </contact>
    <investigator>
      <last_name>Drouillard</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olivie</last_name>
      <email>damien.olivie@chu-rennes.fr</email>
    </contact>
    <investigator>
      <last_name>Olivie</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Nord</name>
      <address>
        <city>Saint Étienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cuilleron</last_name>
      <email>muriel.cuilleron@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>Cuilleron</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Paul Brousse</name>
      <address>
        <city>Villejuif</city>
        <zip>94804</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bellin</last_name>
      <email>marie-france.bellin@bct.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Bellin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Gustave Roussy</name>
      <address>
        <city>Villejuif</city>
        <zip>94805</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dromain</last_name>
      <email>dromain@igr.fr</email>
    </contact>
    <investigator>
      <last_name>Dromain</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 20, 2009</study_first_submitted>
  <study_first_submitted_qc>February 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 23, 2009</study_first_posted>
  <last_update_submitted>February 3, 2010</last_update_submitted>
  <last_update_submitted_qc>February 3, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2010</last_update_posted>
  <responsible_party>
    <name_title>Christophe Aubé</name_title>
    <organization>University Hospital Angers</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

